Home › Melanoma › Montana › Kalispell
Melanoma clinical trials in Kalispell, MT
5 studies for Melanoma are looking for participants at sites in and around Kalispell (within about 30 miles). Open a study to see who can join and how to contact the study team.
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Logan Health Medical Center, Kalispell
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RecruitingPhase 3
- Logan Health Medical Center, Kalispell
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- Kalispell Regional Medical Center, Kalispell
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Logan Health Medical Center, Kalispell
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Logan Health Medical Center, Kalispell
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN32 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Atlanta, GA21 studies
- Columbus, OH21 studies
- Salt Lake City, UT21 studies
- Durham, NC21 studies
Other studies in Kalispell
- Non-Small Cell Lung Cancer9 studies
- Prostate Cancer8 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Colorectal Cancer4 studies
- Bladder Cancer4 studies
- Endometrial Cancer4 studies
- Colon Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Breast Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.